Drugs for Neglected Diseases Initiative
The Drugs for Neglected Diseases initiative is a collaborative, patients' needs-driven, non-profit drug research and development organization that is developing new treatments for neglected diseases, notably leishmaniasis, sleeping sickness, Chagas disease, malaria, filarial diseases, mycetoma, paediatric HIV, and hepatitis C. DNDi's malaria activities were transferred to Medicines for Malaria Venture in 2015. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Drugs for Neglected Diseases Initiative, Switzerland, covering academic research published from 2003 to 2021. Read More.
Open Access Percentage
83%
Total
Publications
426
Total Open
Publications
353
Total
Citations
15K
Open Access
Percentage
83%
Total
Publications
426
Total Open
Publications
353
Total
Citations
15K
Breakdown
Publisher Open
8%
Both
63%
Other Platform Open
12%
Closed
17%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 64%
193
Hybrid 26%
80
No Guarantees 10%
29
Other Platform Open
Domain 88%
280
Institution 53%
168
Public 18%
58
Other Internet 7%
22
Preprint 5%
17
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 279 |
Europe PMC | Domain | 224 |
Semantic Scholar | Public | 53 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 26 |
lshtm.ac.uk OAI-PMH Repository | Institution | 26 |
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia | Institution | 24 |
London School of Hygiene and Tropical Medicine - LSHTM Research Online | Institution | 24 |
University College London - UCL Discovery | Institution | 22 |
Le Centre pour la Communication Scientifique Directe - HAL - Inria | Institution | 14 |
St George's University of London - St George's Online Research Archive | Institution | 12 |